AU3057299A - Sustained-release composition containing cefaclor - Google Patents

Sustained-release composition containing cefaclor

Info

Publication number
AU3057299A
AU3057299A AU30572/99A AU3057299A AU3057299A AU 3057299 A AU3057299 A AU 3057299A AU 30572/99 A AU30572/99 A AU 30572/99A AU 3057299 A AU3057299 A AU 3057299A AU 3057299 A AU3057299 A AU 3057299A
Authority
AU
Australia
Prior art keywords
sustained
composition containing
release composition
containing cefaclor
cefaclor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30572/99A
Other languages
English (en)
Inventor
Hyun Soo Kim
Young Joon Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuhan Corp
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of AU3057299A publication Critical patent/AU3057299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU30572/99A 1998-04-01 1999-04-01 Sustained-release composition containing cefaclor Abandoned AU3057299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9811397 1998-04-01
KR1019980011397A KR100296413B1 (ko) 1998-04-01 1998-04-01 세파클러함유서방성정제
PCT/KR1999/000159 WO1999049868A1 (en) 1998-04-01 1999-04-01 Sustained-release composition containing cefaclor

Publications (1)

Publication Number Publication Date
AU3057299A true AU3057299A (en) 1999-10-18

Family

ID=19535690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30572/99A Abandoned AU3057299A (en) 1998-04-01 1999-04-01 Sustained-release composition containing cefaclor

Country Status (6)

Country Link
EP (1) EP1067937A1 (ja)
JP (1) JP2002509887A (ja)
KR (1) KR100296413B1 (ja)
CN (1) CN1151791C (ja)
AU (1) AU3057299A (ja)
WO (1) WO1999049868A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318495B1 (it) * 2000-05-04 2003-08-25 Lisapharma Spa Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
KR100858945B1 (ko) 2000-06-21 2008-09-17 큐비스트 파마슈티컬즈 인코포레이티드 항미생물제의 경구 흡수를 개선하기 위한 조성물 및 방법
KR20040043589A (ko) * 2002-11-19 2004-05-24 경동제약 주식회사 서방성 세파클러 제제 및 그 제조방법
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
KR100683193B1 (ko) * 2005-07-30 2007-02-15 주식회사유한양행 디클라주릴-함유 약제학적 조성물의 제조방법
TR201000688A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
EP2361615A1 (en) * 2010-02-19 2011-08-31 Alfred E. Tiefenbacher GmbH & Co. KG Dipyridamole prolonged-release tablet
WO2012169677A1 (ko) * 2011-06-09 2012-12-13 주식회사 비씨월드제약 위 체류 및 방출 조절을 위한 조성물
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
EP3031847A1 (en) * 2014-12-11 2016-06-15 Solvay Acetow GmbH Polymer composition comprising basic additive, process and articles comprising said polymer composition
CN104688701A (zh) * 2015-03-20 2015-06-10 江苏亚邦强生药业有限公司 一种头孢克洛片剂及其制备方法
CN114097939B (zh) * 2021-11-19 2024-04-16 上海佩格医院管理有限公司 一种缓释片基质及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations

Also Published As

Publication number Publication date
EP1067937A1 (en) 2001-01-17
JP2002509887A (ja) 2002-04-02
KR100296413B1 (ko) 2001-11-14
WO1999049868A1 (en) 1999-10-07
CN1151791C (zh) 2004-06-02
KR19990079034A (ko) 1999-11-05
CN1303291A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
EG24412A (en) Novel compounds
EG24177A (en) Novel compounds
AU7210598A (en) Novel compounds
AU6804098A (en) Triazinylaminostilbene compounds
AU4260199A (en) Novel compounds
AU2014800A (en) Novel compounds
AU5335798A (en) Stomatic composition
AU5980899A (en) Novel compounds
AU3057299A (en) Sustained-release composition containing cefaclor
AU8747498A (en) Food-preservative composition
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU4814699A (en) Novel compounds
AUPO941497A0 (en) Novel compounds
AU8121998A (en) Composition
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU699057B2 (en) Chemical composition
AU1098499A (en) Emulsifier-lipid composition
AU2187799A (en) Novel taxaneterpine compounds
AU8019998A (en) Fluoromethoximino compounds
AU8863098A (en) Chemical composition
AU7041098A (en) Pi-complex compounds
AU9753998A (en) Azaboroxine compounds
AU1192300A (en) Novel compounds
AU6491399A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase